Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields

Wells Fargo Maintains Equal-Weight on Clorox, Lowers Price Target to $85

Wells Fargo analyst Chris Carey maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $90 to $85.

Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive?

Procter & Gamble faces a $1.4 billion after-tax earnings headwind in fiscal 2027 as it attempts to balance pricing strategies with volume growth in a challenging consumer environment. While pricing contributed to 1% organic sales growth in fiscal 2026, volume remained flat in Q4. PG plans to shift toward more balanced growth through innovation, promotions, and disciplined pricing rather than relying solely on price increases, which risk consumer trade-downs and reduced purchase frequency.

Citigroup Maintains Neutral on Clorox, Lowers Price Target to $97

Citigroup analyst Filippo Falorni maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $100 to $97.

8-K filing — GENERAL MILLS INC (GIS)

Filed: 2026-10-02 AccNo: 0001628280-26-064413 Size: 341 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

General Mills Appoints COO Dana McNabb As CEO, Effective Jan. 1, 2027, Succeeding Jeff Harmening; Harmening Appointed Executive Chair

Barclays Maintains Equal-Weight on General Mills, Raises Price Target to $37

Barclays analyst Andrew Lazar maintains General Mills (NYSE:GIS) with a Equal-Weight and raises the price target from $36 to $37.